Non-surgical drug delivery but with a targeted approach are top priorities to ensure their clinical use for all cancers. Our team is harnessing nano power to encapsulate viruses within bubble-like nanoparticles that allow their simple injection into the bloodstream. Accessibility to new treatments has never been more critical; we bring customised, reliable and high-quality nanoencapsulated viruses for customers globally for research and/or R&D purposes.

We shield viruses in the bloodstream using nanoparticles. This allows for non-surgical delivery as a safer, more cost-effective solution towards virotherapy for ALL cancers where other treatment options have been exhausted. Our nanoparticle platforms:

• Use clinical grade materials that maintain virus viability.
• Provide bespoke target recognition or controlled release.
• Can combine viruses with other drug actives for simple co-administration.
• Are rapidly and reproducibly manufactured using proprietary swirl-mixer technology.